Author archives: Zacks Equity Research

Gilead’s (GILD) Veklury (remdesivir) retains antiviral activity against Omicron, Delta and other emergent SARS-CoV-2 variants in multiple in vitro studies.

Vulcan Materials (VMC) boosts quarterly dividend by 7.5%, given its strong performance and attractive underlying market fundamentals.

Analog Devices’ (ADI) fiscal first-quarter results are likely to reflect strength across automation, signal processing solutions and the battery management system.

Alexander’s (ALX) delivered FFO and revenue surprises of -1.40% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Chubb Limited (CB) stock rallies on the back of new business opportunities, a solid investment portfolio and prudent capital deployment.

Lilly’s (LLY) new antibody-drug, bebtelovimab is authorized to treat certain non-hospitalized adults and pediatric patients with mild-to-moderate COVID-19 who are at high risk of progressing to severe disease

The semiconductor market is on a high owing to soaring demand, which is helping funds like FELIX, FKDNX and FSELX.

SunPower’s (SPWR) Q4 results are expected to reflect a favorable residential business growth trend. However, higher supply chain and labor costs might have hurt earnings

The Cooper Tire buyout boosts Goodyear’s (GT) fourth-quarter sales, taking it to record levels.

Keysight’s (KEYS) performance in first-quarter fiscal 2022 is likely to have benefited from solid demand for its first-to-market solutions across all end markets and regions.